Low prevalence of femoral venous thrombosis after cardiac catheterizations in children: A prospective study

Cardiology in the Young

Volumn 12, Issue 6, 2002, Pages 513-518

  Ruud, Ellen ^a   Natvig, Solveig ^a   Holmstrøm, Henrik ^a   Wesenberg, Finn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clinical investigation; Congenital heart disease; Radiology

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; LIPOPROTEIN A;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; ECHOGRAPHY; FEMORAL VEIN; HEART CATHETERIZATION; HUMAN; PREVALENCE; THROMBOPHILIA; VEIN THROMBOSIS; BLOOD; BRAIN EMBOLISM; CEREBROVASCULAR ACCIDENT; CHILD WELFARE; ENDOSCOPIC ECHOGRAPHY; EVALUATION; FEMALE; INFANT; INFANT WELFARE; MALE; METABOLISM; NORWAY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; FEMALE; FEMORAL VEIN; HEART CATHETERIZATION; HUMANS; INFANT; INFANT WELFARE; INTRACRANIAL EMBOLISM; LIPOPROTEIN(A); MALE; NORWAY; PREVALENCE; PROSPECTIVE STUDIES; THROMBOPHILIA; ULTRASONOGRAPHY, INTERVENTIONAL; VENOUS THROMBOSIS;

EID: 0038282861     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951102000938     Document Type: Article

References (26)

1. Andrew M, Monagle PT, Brooker L. Thromboembolic complications during infancy and childhood. Hamilton, London: B.C. Decker Inc, 2000.
2. Donnelly KM. Venous thromboembolic disease in the pediatric intensive care unit. Curr Opin Pediatr 1999; 11: 213-217.
3. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-1257.
4. Coon PD, Rychik J, Novello RT, Ro PS, Gaynor W, Spray L. Thrombus formation after the Fontan operation. Ann Thorac Surg 2001; 71: 1990-1994.
5. Petaja J, Lunfstrøm U, Sairanen H, Marttinen E, Griffin JH. Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg 1996; 112: 883-889.
6. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001; 119: 344-370S.
7. Allen HD, Clark EB, Gutgesell HP, Driscoll DJ. Moss and Adams' Heart disease in infants, children and adolescents (6th edn). Philadelphia: Lippincott Williams & Wilkins, 2001.
8. Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998; 32: 1433-1440.
9. Wessel DL, Keane JF, Fellows KE, Robichaud H, Lock JE. Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. Am J Cardiol 1986; 58: 347-351.
10. Burrows PE, Benson LN, Babyn P, MacDonald C. Magnetic resonance imaging of the iliofemoral arteries after balloon dilation angioplasty of aortic arch obstructions in children. Circulation 1994; 90: 915-920.
11. Zenz W, Muntean W, Beitzke A, Zobel G, Riccabonna M, Gamillscheg A. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 1993; 70: 382-385.
12. Andrew M, Brooker LA. Blood component therapy in neonatal hemostatic disorders. Transf Med Rev 1995; Vol IX(3): 231-250.
13. Andrew M, Monagle PT, Brooker L. Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. In: Thromboembolic complications during infancy and childhood. Hamilton, London: B.C. Decker Inc, 2000: pp 5-46.
14. Ruud E, Holmstrøm H, Natvig S, Wesenberg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thromboisi in 41 children with cancer - a prospective study. Med Pediatr Oncol 2002; 38: 405-410.
15. Saxena A, Gupta R, Kumar KR, Kothari SS, Wasir HS. Predictors of arterial thrombosis after diagnostic cardiac catheterizations in infants and children randomized to two heparin dosages. Cathet Cardiovasc Diagn 1997; 41: 400-403.
16. Freed MD, Rosenthal A, Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin. Am Heart J 1974; 87: 283-286.
17. Freed MD, Keane JF, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterizations in children. Circulation 1974; 50: 565-569.
18. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters. A metaanalysis of randomised controlled trials. Chest 1998; 113: 165-171.
19. Montalescot G, Cohen M. Low molecular weight heparins in the cardiac catheterization laboratory. J Thromb & Thrombol 1999; 7: 319-323.
20. Taylor A, Beveridge R, Barry M et al. Guidelines for the use of imaging techniques for the investigation of venous thromboembolic disease. J Emerg Med 1998; 16: 663-668.
21. Mathews RA, Park SC, Neches WH, Fricker FJ, Lenox CC, Zuberbuhler JR. Iliac venous thrombosis in infants and children after cardiac catheterizations. Cathet cardiovasc Diagn 1979; 5: 67-74.
22. Kuehl KS, Perry LW, Scott LP. Thrombosis of the inferior vena cava in patients with cyanotic congenital heart disease. J Pediatr 1971; 79: 430-435.
23. Wigger HJ, Bransilver BR, Blanc WA. Thromboses due to catheterization in infants and children. J Pediatr 1970; 76: 1-11.
24. Connors AF, Castele RJ, Farhat NZ, Tomashefski JF. Complications of right heart catheterization. A prospective autopsy study. Chest 1985; 88: 567-572.
25. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian childhood thrombophilia registry. Ped Research 2000; 47: 763-766.
26. Hausler M, Hubner D, Delhaas T, Muhler EG. Long term complications of inferior vena cava thrombosis. Arch Dis Child 2001; 85: 228-233.